Cargando…

Development and Validation of a Web-Based Severe COVID-19 Risk Prediction Model

BACKGROUND: Coronavirus disease 2019 (COVID-19) carries high morbidity and mortality globally. Identification of patients at risk for clinical deterioration upon presentation would aid in triaging, prognostication, and allocation of resources and experimental treatments. RESEARCH QUESTION: Can we de...

Descripción completa

Detalles Bibliográficos
Autores principales: Woo, Sang H., Rios-Diaz, Arturo J., Kubey, Alan A., Cheney-Peters, Dianna R., Ackermann, Lily L., Chalikonda, Divya M., Venkataraman, Chantel M., Riley, Joshua M., Baram, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Southern Society for Clinical Investigation. Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141270/
https://www.ncbi.nlm.nih.gov/pubmed/34029558
http://dx.doi.org/10.1016/j.amjms.2021.04.001
_version_ 1783696331179556864
author Woo, Sang H.
Rios-Diaz, Arturo J.
Kubey, Alan A.
Cheney-Peters, Dianna R.
Ackermann, Lily L.
Chalikonda, Divya M.
Venkataraman, Chantel M.
Riley, Joshua M.
Baram, Michael
author_facet Woo, Sang H.
Rios-Diaz, Arturo J.
Kubey, Alan A.
Cheney-Peters, Dianna R.
Ackermann, Lily L.
Chalikonda, Divya M.
Venkataraman, Chantel M.
Riley, Joshua M.
Baram, Michael
author_sort Woo, Sang H.
collection PubMed
description BACKGROUND: Coronavirus disease 2019 (COVID-19) carries high morbidity and mortality globally. Identification of patients at risk for clinical deterioration upon presentation would aid in triaging, prognostication, and allocation of resources and experimental treatments. RESEARCH QUESTION: Can we develop and validate a web-based risk prediction model for identification of patients who may develop severe COVID-19, defined as intensive care unit (ICU) admission, mechanical ventilation, and/or death? METHODS: This retrospective cohort study reviewed 415 patients admitted to a large urban academic medical center and community hospitals. Covariates included demographic, clinical, and laboratory data. The independent association of predictors with severe COVID-19 was determined using multivariable logistic regression. A derivation cohort (n=311, 75%) was used to develop the prediction models. The models were tested by a validation cohort (n=104, 25%). RESULTS: The median age was 66 years (Interquartile range [IQR] 54-77) and the majority were male (55%) and non-White (65.8%). The 14-day severe COVID-19 rate was 39.3%; 31.7% required ICU, 24.6% mechanical ventilation, and 21.2% died. Machine learning algorithms and clinical judgment were used to improve model performance and clinical utility, resulting in the selection of eight predictors: age, sex, dyspnea, diabetes mellitus, troponin, C-reactive protein, D-dimer, and aspartate aminotransferase. The discriminative ability was excellent for both the severe COVID-19 (training area under the curve [AUC]=0.82, validation AUC=0.82) and mortality (training AUC= 0.85, validation AUC=0.81) models. These models were incorporated into a mobile-friendly website. CONCLUSIONS: This web-based risk prediction model can be used at the bedside for prediction of severe COVID-19 using data mostly available at the time of presentation.
format Online
Article
Text
id pubmed-8141270
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Southern Society for Clinical Investigation. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-81412702021-05-24 Development and Validation of a Web-Based Severe COVID-19 Risk Prediction Model Woo, Sang H. Rios-Diaz, Arturo J. Kubey, Alan A. Cheney-Peters, Dianna R. Ackermann, Lily L. Chalikonda, Divya M. Venkataraman, Chantel M. Riley, Joshua M. Baram, Michael Am J Med Sci Clinical Investigation BACKGROUND: Coronavirus disease 2019 (COVID-19) carries high morbidity and mortality globally. Identification of patients at risk for clinical deterioration upon presentation would aid in triaging, prognostication, and allocation of resources and experimental treatments. RESEARCH QUESTION: Can we develop and validate a web-based risk prediction model for identification of patients who may develop severe COVID-19, defined as intensive care unit (ICU) admission, mechanical ventilation, and/or death? METHODS: This retrospective cohort study reviewed 415 patients admitted to a large urban academic medical center and community hospitals. Covariates included demographic, clinical, and laboratory data. The independent association of predictors with severe COVID-19 was determined using multivariable logistic regression. A derivation cohort (n=311, 75%) was used to develop the prediction models. The models were tested by a validation cohort (n=104, 25%). RESULTS: The median age was 66 years (Interquartile range [IQR] 54-77) and the majority were male (55%) and non-White (65.8%). The 14-day severe COVID-19 rate was 39.3%; 31.7% required ICU, 24.6% mechanical ventilation, and 21.2% died. Machine learning algorithms and clinical judgment were used to improve model performance and clinical utility, resulting in the selection of eight predictors: age, sex, dyspnea, diabetes mellitus, troponin, C-reactive protein, D-dimer, and aspartate aminotransferase. The discriminative ability was excellent for both the severe COVID-19 (training area under the curve [AUC]=0.82, validation AUC=0.82) and mortality (training AUC= 0.85, validation AUC=0.81) models. These models were incorporated into a mobile-friendly website. CONCLUSIONS: This web-based risk prediction model can be used at the bedside for prediction of severe COVID-19 using data mostly available at the time of presentation. Southern Society for Clinical Investigation. Published by Elsevier Inc. 2021-10 2021-05-23 /pmc/articles/PMC8141270/ /pubmed/34029558 http://dx.doi.org/10.1016/j.amjms.2021.04.001 Text en © 2021 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Clinical Investigation
Woo, Sang H.
Rios-Diaz, Arturo J.
Kubey, Alan A.
Cheney-Peters, Dianna R.
Ackermann, Lily L.
Chalikonda, Divya M.
Venkataraman, Chantel M.
Riley, Joshua M.
Baram, Michael
Development and Validation of a Web-Based Severe COVID-19 Risk Prediction Model
title Development and Validation of a Web-Based Severe COVID-19 Risk Prediction Model
title_full Development and Validation of a Web-Based Severe COVID-19 Risk Prediction Model
title_fullStr Development and Validation of a Web-Based Severe COVID-19 Risk Prediction Model
title_full_unstemmed Development and Validation of a Web-Based Severe COVID-19 Risk Prediction Model
title_short Development and Validation of a Web-Based Severe COVID-19 Risk Prediction Model
title_sort development and validation of a web-based severe covid-19 risk prediction model
topic Clinical Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141270/
https://www.ncbi.nlm.nih.gov/pubmed/34029558
http://dx.doi.org/10.1016/j.amjms.2021.04.001
work_keys_str_mv AT woosangh developmentandvalidationofawebbasedseverecovid19riskpredictionmodel
AT riosdiazarturoj developmentandvalidationofawebbasedseverecovid19riskpredictionmodel
AT kubeyalana developmentandvalidationofawebbasedseverecovid19riskpredictionmodel
AT cheneypetersdiannar developmentandvalidationofawebbasedseverecovid19riskpredictionmodel
AT ackermannlilyl developmentandvalidationofawebbasedseverecovid19riskpredictionmodel
AT chalikondadivyam developmentandvalidationofawebbasedseverecovid19riskpredictionmodel
AT venkataramanchantelm developmentandvalidationofawebbasedseverecovid19riskpredictionmodel
AT rileyjoshuam developmentandvalidationofawebbasedseverecovid19riskpredictionmodel
AT barammichael developmentandvalidationofawebbasedseverecovid19riskpredictionmodel